🚀 VC round data is live in beta, check it out!
Pilulka Lekarny Valuation Multiples
Discover revenue and EBITDA valuation multiples for Pilulka Lekarny and similar public comparables like Wellgistics Health, Laxus Technologies, Westwing Brasil, MERLIN GROUP and more.
Pilulka Lekarny Overview
About Pilulka Lekarny
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.
Founded
2014
HQ
Employees
N/A
Website
Financials (FY)
EV
$20M
Pilulka Lekarny Financials
Pilulka Lekarny reported last fiscal year revenue of $63M and negative EBITDA of ($2M).
In the same fiscal year, Pilulka Lekarny generated $6M in gross profit, ($2M) in EBITDA losses, and had net loss of ($6M).
Pilulka Lekarny P&L
In the most recent fiscal year, Pilulka Lekarny reported revenue of $63M and EBITDA of ($2M).
Pilulka Lekarny expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $63M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $6M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 9% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($2M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (4%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (7%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($6M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (10%) | XXX | XXX | XXX |
| Net Debt | — | — | $2M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Pilulka Lekarny Stock Performance
Pilulka Lekarny has current market cap of $18M, and enterprise value of $20M.
Market Cap Evolution
Pilulka Lekarny's stock price is $6.69.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $20M | $18M | 2.0% | XXX | XXX | XXX | $-2.25 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPilulka Lekarny Valuation Multiples
Pilulka Lekarny trades at 0.3x EV/Revenue multiple, and (8.3x) EV/EBITDA.
Pilulka Lekarny Financial Valuation Multiples
As of April 18, 2026, Pilulka Lekarny has market cap of $18M and EV of $20M.
Equity research analysts estimate Pilulka Lekarny's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Pilulka Lekarny has a P/E ratio of (3.0x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $18M | XXX | $18M | XXX | XXX | XXX |
| EV (current) | $20M | XXX | $20M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.3x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (8.3x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (4.3x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 3.6x | XXX | XXX | XXX |
| P/E | — | XXX | (3.0x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (6.3x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Pilulka Lekarny Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Pilulka Lekarny Margins & Growth Rates
Pilulka Lekarny's revenue in the last fiscal year declined by (39%).
Pilulka Lekarny Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (39%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (4%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (46%) | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 16% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Pilulka Lekarny Public Comps
See public comps and valuation multiples for other Consumer E-commerce and Pharmacies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Pilulka Lekarny | XXX | XXX | XXX | XXX | XXX | XXX |
| Wellgistics Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Laxus Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| Westwing Brasil | XXX | XXX | XXX | XXX | XXX | XXX |
| MERLIN GROUP | XXX | XXX | XXX | XXX | XXX | XXX |
| MOGU | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Pilulka Lekarny M&A Activity
Pilulka Lekarny acquired XXX companies to date.
Last acquisition by Pilulka Lekarny was on XXXXXXXX, XXXXX. Pilulka Lekarny acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Pilulka Lekarny
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialPilulka Lekarny Investment Activity
Pilulka Lekarny invested in XXX companies to date.
Pilulka Lekarny made its latest investment on XXXXXXXX, XXXXX. Pilulka Lekarny invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Pilulka Lekarny
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Pilulka Lekarny
| When was Pilulka Lekarny founded? | Pilulka Lekarny was founded in 2014. |
| Where is Pilulka Lekarny headquartered? | Pilulka Lekarny is headquartered in Czech Republic. |
| Is Pilulka Lekarny publicly listed? | Yes, Pilulka Lekarny is a public company listed on Prague Stock Exchange. |
| What is the stock symbol of Pilulka Lekarny? | Pilulka Lekarny trades under PINK ticker. |
| When did Pilulka Lekarny go public? | Pilulka Lekarny went public in 2020. |
| Who are competitors of Pilulka Lekarny? | Pilulka Lekarny main competitors are Wellgistics Health, Laxus Technologies, Westwing Brasil, MERLIN GROUP. |
| What is the current market cap of Pilulka Lekarny? | Pilulka Lekarny's current market cap is $18M. |
| What is the current revenue of Pilulka Lekarny? | Pilulka Lekarny's last fiscal year revenue is $63M. |
| What is the current EV/Revenue multiple of Pilulka Lekarny? | Current revenue multiple of Pilulka Lekarny is 0.3x. |
| Is Pilulka Lekarny profitable? | No, Pilulka Lekarny is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.